-
Sanofi Invests $679M in Two French Vaccine Sites
contractpharma
June 17, 2020
Will create a state-of-the-art vaccine production site and a new research center dedicated to vaccines.
-
BioNTech to receive up to €100m from EIB for vaccine development
pharmaceutical-technology
June 15, 2020
German immunotherapy company BioNTech has signed a €100m debt financing agreement with the European Investment Bank (EIB) for the development of its Covid-19 vaccine candidate, BNT162.
-
EMA gives positive opinion to investigational Ebola vaccine regimen
europeanpharmaceuticalreview
June 09, 2020
Developed by Janssen, the two-dose regimen has already been given to 60,000 patients and now has the positive opinion of the Committee for Medicinal Products for Human Use (CHMP).
-
Australia’s CSL says to help fund, make vaccine candidate if it proves successful
expresspharma
June 08, 2020
Early pre-clinical results for the vaccine candidate have shown it produced high levels of antibodies that can neutralise the virus, CSL said.
-
Te Herenga Waka—Victoria University, NZ professor receives funding boost for vaccine research
expresspharma
June 03, 2020
Te Herenga Waka—Victoria University of Wellington Associate Professor Bridget Stocker has received a significant funding boost for vaccine research that has potential to help with diseases ranging from bowel cancer to COVID-19.
-
New vaccine for Ebola among CHMP recommendations
pharmatimes
June 02, 2020
Johnson and Johnson's experimental two-stage vaccine for protection against Ebola virus disease is among eight medicines backed by the European Medicines Agency's human medicines committee (CHMP) at its May meeting.
-
30 countries launch initiative to share COVID-19 tools
expresspharma
June 02, 2020
It comes amid concerns that rich countries pumping resources into finding will muscle their way to the front of the queue, once a candidate succeeds.
-
Pharma leaders, policy makers discuss COVID-19 impact, way forward for industry
expresspharma
June 02, 2020
Most are optimistic about the future but accentuate the need for investments in technology and other strategic measures to ensure progress.
-
CordenPharma & Moderna Extend Manufacturing Agreement
contractpharma
June 01, 2020
For the supply of lipid excipients to be used in Moderna's coronavirus vaccine.
-
AstraZeneca says it may consider exposing vaccine trial participants to virus
expresspharma
June 01, 2020
The British drugmaker last week started phase 2 and 3 trials of the vaccine, looking to recruit around 10,000 adults and children in Britain.